PURPOSE: A significant discrepancy between measured oxygen consumption (VO(2)) (via ventilatory expired gas analysis) and estimated VO(2) (via the imposed workload) frequently is reported in the heart failure (HF) population during symptom-limited exercise testing. The purpose of this investigation was to examine the difference between measured and estimated VO(2) (VO(2) discrepancy) during a highly conservative ramping protocol. METHODS: For this study, 28 subjects with compensated HF (20 men and 8 women; age, 51.1 +/- 14.6 years) and 19 healthy control subjects (age-, gender-, and activity-matched to an HF subgroup) underwent symptom-limited exercise testing (treadmill) with ventilatory expired gas analysis. RESULTS: Peak estimated and measured VO(2) values were significantly higher in the age-, gender-, and activity-matched control group than in the HF group, but the change in measured VO(2) per change in estimated VO(2) (Deltameasured/Deltaestimated VO(2) slope) and the VO(2) discrepancy did not reach statistical significance. Peak estimated VO(2) was a significant predictor of peak measured VO(2) in the overall HF group (R2 = 0.90; P <.001). CONCLUSIONS: Although estimated VO(2) is not considered a replacement for measured VO(2), these results indicate that a highly conservative exercise protocol may allow for a more accurate prediction of peak measured VO(2) via the estimated oxygen cost for a given workload in patients with compensated HF.
PURPOSE: A significant discrepancy between measured oxygen consumption (VO(2)) (via ventilatory expired gas analysis) and estimated VO(2) (via the imposed workload) frequently is reported in the heart failure (HF) population during symptom-limited exercise testing. The purpose of this investigation was to examine the difference between measured and estimated VO(2) (VO(2) discrepancy) during a highly conservative ramping protocol. METHODS: For this study, 28 subjects with compensated HF (20 men and 8 women; age, 51.1 +/- 14.6 years) and 19 healthy control subjects (age-, gender-, and activity-matched to an HF subgroup) underwent symptom-limited exercise testing (treadmill) with ventilatory expired gas analysis. RESULTS: Peak estimated and measured VO(2) values were significantly higher in the age-, gender-, and activity-matched control group than in the HF group, but the change in measured VO(2) per change in estimated VO(2) (Deltameasured/Deltaestimated VO(2) slope) and the VO(2) discrepancy did not reach statistical significance. Peak estimated VO(2) was a significant predictor of peak measured VO(2) in the overall HF group (R2 = 0.90; P <.001). CONCLUSIONS: Although estimated VO(2) is not considered a replacement for measured VO(2), these results indicate that a highly conservative exercise protocol may allow for a more accurate prediction of peak measured VO(2) via the estimated oxygen cost for a given workload in patients with compensated HF.
Authors: Justin McNair Canada; Antonio Abbate; Rebecca Collen; Hayley Billingsley; Leo Francis Buckley; Salvatore Carbone; Cory Ross Trankle; Michael Ola Idowu; Dinesh Kadariya; Benjamin Van Tassell; Arun Jayant Sanyal; Mohammad Shadab Siddiqui Journal: Am J Cardiol Date: 2018-11-06 Impact factor: 2.778
Authors: Joseph F Norman; Bunny J Pozehl; Kathleen A Duncan; Melody A Hertzog; Ahmed S Elokda; Steven K Krueger Journal: J Cardiopulm Rehabil Prev Date: 2009 Sep-Oct Impact factor: 2.081
Authors: Benjamin W Van Tassell; Leo F Buckley; Salvatore Carbone; Cory R Trankle; Justin M Canada; Dave L Dixon; Nayef Abouzaki; Claudia Oddi-Erdle; Giuseppe Biondi-Zoccai; Ross Arena; Antonio Abbate Journal: Clin Cardiol Date: 2017-05-05 Impact factor: 2.882
Authors: Cory R Trankle; Justin M Canada; Dinesh Kadariya; Roshanak Markley; Horacio Medina De Chazal; Janet Pinson; Adam Fox; Benjamin W Van Tassell; Antonio Abbate; Daniel Grinnan Journal: Am J Respir Crit Care Med Date: 2019-02-01 Impact factor: 21.405
Authors: Benjamin W Van Tassell; Justin Canada; Salvatore Carbone; Cory Trankle; Leo Buckley; Claudia Oddi Erdle; Nayef A Abouzaki; Dave Dixon; Dinesh Kadariya; Sanah Christopher; Aaron Schatz; Jessica Regan; Michele Viscusi; Marco Del Buono; Ryan Melchior; Pranav Mankad; Juan Lu; Robin Sculthorpe; Giuseppe Biondi-Zoccai; Edward Lesnefsky; Ross Arena; Antonio Abbate Journal: Circ Heart Fail Date: 2017-11 Impact factor: 8.790
Authors: Luiz Eduardo Ritt; Ricardo Brandão Oliveira; Jonathan Myers; Ross Arena; Mary Ann Peberdy; Daniel Bensimhon; Paul Chase; Daniel Forman; Marco Guazzi Journal: J Cardiopulm Rehabil Prev Date: 2012 May-Jun Impact factor: 2.081
Authors: Justin M Canada; Tae Shik Park; Krishna Ravindra; Juan G Chiabrando; Marco Giuseppe Del Buono; Jessie van Wezenbeek; Cory R Trankle; Dinesh Kadariya; Larry Keen; Salvatore Carbone; Hayley Billingsley; George F Wohlford; Ross Arena; Benjamin W Van Tassell; Antonio Abbate Journal: J Cardiopulm Rehabil Prev Date: 2022-01-01 Impact factor: 2.081
Authors: Bernice C Yates; Joseph Norman; Jane Meza; Kaye Stanek Krogstrand; Susana Harrington; Scott Shurmur; Matthew Johnson; Karen Schumacher Journal: J Cardiovasc Nurs Date: 2015 Mar-Apr Impact factor: 2.083
Authors: Benjamin W Van Tassell; Cory R Trankle; Justin M Canada; Salvatore Carbone; Leo Buckley; Dinesh Kadariya; Marco G Del Buono; Hayley Billingsley; George Wohlford; Michele Viscusi; Claudia Oddi-Erdle; Nayef A Abouzaki; Dave Dixon; Giuseppe Biondi-Zoccai; Ross Arena; Antonio Abbate Journal: Circ Heart Fail Date: 2018-08 Impact factor: 8.790